
Advancing diabetic foot care before complications arise with precision at every step. DiabeTech is pioneering the world's first AI-powered biosensor sock, engineered to detect diabetic foot complications at their earliest stage long before they escalate into life-altering medical emergencies.
"Over 150,000 lower-limb amputations occur in the United States every year — nearly all linked to diabetes. We believe no patient should lose a limb to a complication that could have been caught sooner."
Diabetech's team combines deep expertise in healthcare technology, clinical outcomes, and patient-centered design to transform how diabetic foot ulcers are managed.

Founder and CEO
Founder & CEO · AI Business Strategist · 2x Patent-Pending Innovator · Tosin Alabi is a visionary founder and AI business strategist building DiabeTech at the intersection of healthcare, artificial intelligence, and human impact. Her journey is deeply personal. DiabeTech was created in response to the preventable loss of her father to diabetic complications, fueling her mission to transform how diabetes is monitored, managed, and ultimately prevented. A serial entrepreneur with a global footprint, Tosin has scaled ventures across four continents and built a network of over 2,000 merchants. She combines technical innovation with commercial strategy to develop scalable, real-world solutions that drive measurable impact. She holds an MBA from the Whitman School of Management at Syracuse University and brings a multidisciplinary approach that blends business leadership, AI-driven innovation, and healthcare insight. Her work and entrepreneurial vision have earned recognition on the NASDAQ billboard and through collaborations with leading institutions and organizations across healthcare, technology, and innovation ecosystems. Tosin is committed to building the future of proactive healthcare where intelligence, data, and innovation come together to save lives and improve outcomes globally.
We're a lean, focused team based in New York driving real change in DFU management through innovative technology and personalized care.
1
Dedicated founder
Tosin Jasmine leads Diabetech with direct focus on solving DFU management challenges.
1
Location
Based in New York, developing technology that serves patients and providers nationwide.
2
Core capabilities
Mobile platform technology combined with personalized care delivery for comprehensive DFU support.
24/7
Platform access
Diabetech's mobile platform is available whenever patients and providers need support for DFU management.
Reach out to Diabetech to discuss partnerships, learn more about our platform, or explore how we can support your DFU management goals.
Diabetech partners with leading healthcare systems, clinics, and digital health platforms to expand access to evidence-based DFU management and improve patient outcomes.






